Explore Resources

21 CFR Part 11 - eSignature12 min readUpdated 2026

21 CFR Part 11 eSignature Software for Pharma: Requirements, Checklist & Validation Guide (2026)

Electronic signatures are everywhere in pharma and CRO workflows, but in regulated environments, eSignature must meet 21 CFR Part 11 (and often EU Annex 11) expectations. This guide turns the regulation into concrete system controls, validation evidence, and a copy-paste checklist you can use for audits and vendor evaluations.

eSignature and 21 CFR Part 11 compliance

Quick Summary (for QA, IT, and Clinical Ops)

You'll learn:

  • What makes an eSignature Part 11 compliant
  • Which controls and evidence auditors expect to see
  • A practical Part 11 eSignature checklist (ready to use)
  • What to document for validation (CSV / CSA style)

Best for: Sponsors, CROs, Pharma QA, IT, and vendors implementing eSignature systems for regulated records.

What is 21 CFR Part 11?

21 CFR Part 11 sets requirements for when electronic records and electronic signatures can be considered trustworthy, reliable, and equivalent to paper records and handwritten signatures.

If your process produces regulated records (clinical, quality, manufacturing, pharmacovigilance, training, etc.), and you use a system to sign/approve them electronically, you must ensure the system supports:

  • Identity + intent of the signer
  • Integrity of the record (no silent changes)
  • Traceability (audit trail)
  • Security and access control
  • Availability of records (retention + retrieval)

What counts as an electronic signature?

An electronic signature (eSignature) in regulated use typically means:

  • A user performs an approval/sign action that is uniquely linked to their identity
  • The system captures who signed, when, and why (meaning of signature)
  • The signature is bound to the record so it cannot be removed, copied, or reused improperly
  • The signed record remains tamper-evident and traceable

In pharma/CRO environments, eSignatures commonly apply to:

  • SOPs, policies, and controlled documents
  • Deviations, CAPA, change control, investigations
  • Protocols, amendments, monitoring reports, approvals
  • Training assignments and completion sign-offs
  • Vendor qualification and quality agreements

Core Part 11 requirements for eSignature software

Below are the requirements auditors usually "walk through" when reviewing an eSignature system.

Unique user identity & authentication

A Part 11 eSignature must be attributable to a single person. Best-practice system controls include:

  • Unique user IDs (no shared accounts)
  • Strong password policy + lockout
  • Session controls / timeout
  • Optional MFA (recommended)
  • Controlled user provisioning and de-provisioning

Audit expectation: documented roles/responsibilities + evidence of access control management.

Signature manifestation (what must appear on the signed record)

The signed record should clearly show:

  • Printed name of signer
  • Date/time of signing
  • Meaning of signature (e.g., approval, review, authorship)

Audit expectation: the signature info is visible in the record output (PDF/print view/export).

Signature is linked to the record (cannot be copied/reused)

Part 11 expects signatures to be tied to the specific record instance. Controls that support this:

  • Signature is embedded/bound to the document/version
  • Any post-sign change triggers versioning and requires re-approval
  • "Final" records are protected from silent edits

Audit expectation: users cannot replace content after approval without traceable change + new approval.

System access controls (role-based and least privilege)

Your system should ensure only authorized users can:

  • View records
  • Edit/prepare
  • Route for approval
  • Sign/approve
  • Administer system settings

Audit expectation: role matrix + evidence that roles are enforced in the system.

Audit trail requirements: what "secure" means

A secure, computer-generated, time-stamped audit trail is one of the most critical Part 11 areas.

A compliant audit trail should capture (at minimum):

  • Who did what (create/edit/submit/approve/reject)
  • When it happened (timestamp)
  • What changed (old value/new value where applicable)
  • Why (reason for change/approval meaning)

Also important:

  • Audit trail must be non-editable
  • Must be retained for the same period as the record
  • Must be available for review/export during audits

Practical tip: auditors often ask for a "before/after" example and an export of audit trail events.

Validation evidence: CSV vs CSA (what to keep audit-ready)

Whether your organization uses traditional CSV or a more CSA/risk-based approach, the goal is the same: prove the system is fit for intended use and controls are effective.

Minimum validation package for an eSignature system

Keep these audit-ready:

  • Intended use statement + system description
  • Requirements (URS) focused on Part 11 controls
  • Risk assessment (GxP impact + data integrity)
  • Test evidence for critical controls: Access control & roles; eSignature actions + manifestation; Audit trail generation + immutability; Record versioning and change control; Backup/restore (availability); Security controls (as applicable)
  • Traceability (requirements → tests)
  • SOPs: user access management, change control, incident handling
  • Periodic review plan (where required)

Key idea: test depth should match risk—eSign + audit trails are typically high risk.

Common audit findings (and how to avoid them)

Here are frequent issues seen during audits/inspections:

IssueFix
Shared accounts or weak access controlEnforce unique IDs, remove generic users, document provisioning.
Audit trail missing critical eventsEnsure audit trail covers create/edit/submit/approve/reject and metadata changes.
Post-approval edits without re-approvalVersioning + workflow rules; prevent "silent" edits.
Signature meaning not capturedRequire "meaning of signature" (review/approve/author) in workflow.
Validation not focused on Part 11 controlsRisk-based test pack aligned to regulatory expectations.

21 CFR Part 11 eSignature Compliance Checklist

Use this checklist to evaluate your eSignature software (vendor or internal).

Identity & Access

  • Unique user IDs (no shared accounts)
  • Role-based access control (least privilege)
  • Password policy + lockout + session timeout
  • User provisioning/de-provisioning procedure documented
  • Optional MFA available (recommended)

eSignature Controls

  • Signature captures printed name + date/time + meaning
  • Signature requires user authentication at time of signing (per policy)
  • Signature is bound to the specific record/version
  • System prevents signature copying/reuse
  • Post-approval changes trigger versioning + re-approval

Audit Trail

  • Computer-generated, time-stamped audit trail enabled
  • Captures create/edit/submit/approve/reject events
  • Records old/new values (where applicable)
  • Audit trail is non-editable and retained with record
  • Audit trail can be reviewed and exported for auditors

Record Integrity & Retention

  • Records are protected from unauthorized alteration
  • Record retention + retrieval supports audit requirements
  • Exported records (PDF/CSV) maintain signature manifestation
  • Backup and restore are defined and tested

Validation & Documentation

  • Intended use + URS include Part 11 requirements
  • Risk assessment completed (GxP impact, ALCOA+)
  • Test evidence for critical controls is available
  • Traceability matrix maintained (requirements → tests)
  • SOPs cover access control, change control, incidents, periodic review

How Techy Sign supports Part 11 readiness

Techy Sign is designed for regulated teams who need speed without compromising compliance.

Typical capabilities include:

  • Configurable workflows for review/approval/signature routes
  • Signature manifestation (name, timestamp, meaning) on signed outputs
  • Tamper-evident audit trails for key record events
  • Role-based access control aligned to QA/IT governance
  • Export-ready records for audits and submissions
  • Validation support artifacts (requirements/test guidance aligned to risk)

Use cases in pharma/CROs:

  • SOP and controlled document approvals
  • Quality workflows (deviation/CAPA/change control approvals)
  • Study documentation sign-offs
  • Training acknowledgements and approvals
  • Vendor qualification sign approvals

CTA: If you want a faster vendor qualification cycle, request a Techy Sign Part 11 readiness pack from our team.

Explore Techy Sign eSignature →

Final Takeaway

For regulated teams, the goal is simple: prove who signed, what they signed, when they signed, why they signed, and that the record remained trustworthy afterward.

If your eSignature system can demonstrate that with clear evidence, audits become dramatically easier.

FAQs

Frequently Asked Questions

Not exactly. Compliance is achieved through system capabilities + your procedures + validation evidence. A tool can be "Part 11 ready," but your organization must implement it correctly.

In most regulated use cases, yes—especially where records can change or where approvals must be traceable.

Part 11 is US FDA-focused on electronic records/signatures. Annex 11 is EU GMP-focused and emphasizes validation, security, and data integrity. Many organizations align to both.

At minimum: intended use, URS, risk assessment, test evidence for critical controls, traceability, and SOP coverage (access, change control, incidents).

Yes—commonly. The key is that the system supports identity, intent, record integrity, and auditability, and that you validate the intended use.